泌尿系统肿瘤第八版TNM分期更新解读
本文阐述AJCC与UICC第八版TNM分期中泌尿系统肿瘤的主要变化,包括新定义的TNM类别与预后分期分组、既往类别的澄清与细化,以及预后因素更系统的呈现;睾丸、阴茎和前列腺癌的TNM分类定义有重大改变,旨在改善患者预后分层与管理。
要点
- 第八版TNM分期中睾丸、阴茎和前列腺癌的TNM分类定义有重大改变。
- AJCC与UICC第八版同期发布,但两者在泌尿系统肿瘤分期中存在差异。
- AJCC分期手册新增影像学扩展章节、显著变化的证据等级及风险模型认可。
核心结论
- 第八版TNM分期对泌尿系统肿瘤的分期类别更新可归为三组:新定义的TNM类别与预后分期分组、既往类别的澄清与细化、预后因素更系统且扩展的呈现。
- 睾丸、阴茎和前列腺癌的TNM分类定义有重大改变,旨在改善患者预后分层与管理。
研究设计与样本
- 由美国癌症联合委员会(AJCC)与国际抗癌联盟(UICC)联合制定的第八版TNM分期,两者同期发布两个版本。
- 更新通过获取最佳证据、利用 interdisciplinary 资源(包括共识推荐)及增强数据分析生成。
主要发现
- AJCC与UICC的目标是拥有相同的TNM分期系统,但两个出版物之间存在差异,包括泌尿系统肿瘤的分期。
- AJCC分期手册新增多个方面,包括影像学扩展章节、显著变化的证据等级呈现、以及认可通过AJCC质量标准的前列腺癌等风险预测模型。
- 第八版AJCC分期采纳了阴茎癌(WHO/ISUP分级)、前列腺癌(Grade group)和肾癌(WHO/ISUP核仁分级)的新分级方法。
- AJCC分期手册的许多更新也包含在第八版UICC TNM分期中。
关键数值与推荐
- 睾丸、阴茎和前列腺癌的TNM分类定义有重大改变。
- 阴茎癌采用WHO/ISUP分级,前列腺癌采用Grade group,肾癌采用WHO/ISUP核仁分级。
临床怎么用
- 临床上应采用第八版TNM分期对泌尿系统肿瘤进行分期,注意睾丸、阴茎和前列腺癌的TNM分类定义变化。
- 需注意AJCC与UICC第八版在泌尿系统肿瘤分期中的差异。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: The Tumor-Node-Metastasis (TNM) classification on cancer staging, jointly developed by the American Joint Commission on Cancer (AJCC) and the Union for International Cancer Control (UICC), has been updated to its 8th edition with two contemporaneous versions published by the AJCC and UICC. While the goal of the AJCC and UICC is to have identical TNM staging systems, differences exist between these two publications including in the staging of urologic cancers. Among several new facets in the AJCC staging manual, a select few of greater import include an expanded section on imaging, presentation of levels of evidence for significant changes, and endorsement of risk assessment models that pass the AJCC quality criteria such as in prostate cancer. The updates for urologic cancers in the AJCC stage categories can be grouped into: (1) newly defined TNM categories and prognostic stage groupings, (2) clarifications and refinements of previously defined categories, and (3) more systematic and expanded presentation of prognostic factors. Changes are harmonized with the current reporting and treatment guidelines. Contributions from genitourinary pathology are evident in the AJCC classification from many of the International Society of Urological Pathology (ISUP) consensus conferences on prostate, kidney, testicular, and penile neoplasms that addressed staging issues and the timely publication of the 4th edition of the World Health Organization (WHO) classification of urinary and male genital organ tumors. New grading approaches for penile (WHO/ISUP grade), prostate (Grade group), and kidney (WHO/ISUP nucleolar grade) cancers were adopted in the AJCC system. Many of these updates in the AJCC staging manual are also included in the 8th UICC TNM edition. In an effort to achieve the optimal staging recommendations for urologic cancers, updates in the 8th TNM edition were generated through the acquisition of best evidences, tapping interdisciplinary resources including consensus recommendations, and enhanced data analysis. PATIENT SUMMARY: In this report, we explain the seminal changes in the 8th edition of the Tumor-Node-Metastasis staging system for urologic cancers. Major stage category definitional changes are in Tumor-Node-Metastasis classifications of testicular, penile, and prostate cancer which improve patient stratification for prognosis and management.
引用
- Paner GP, Stadler WM, Hansel DE, et al. Updates in the Eighth Edition of the Tumor-Node-Metastasis Staging Classification for Urologic Cancers. Eur Urol. 2018. PMID: 29325693. doi:10.1016/j.eururo.2017.12.018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。